Nucleic Acid Pathogen Testing - Cigna

← Back to document page

Medical Coverage Policy Effective Date ........................................ ..... 9/15/2021. Next Review 1/15/2022. Coverage Policy Number .................................. 0530. Nucleic acid Pathogen Testing Table of Contents Related Coverage Resources Overview ........................................ ...................... 1 Preventive Care Services Coverage General Background ........................................ ....3. Medicare Coverage Determinations ....................8. Coding/Billing Information ....................................9. References ........................................ ................36. INSTRUCTIONS FOR USE. The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations.

document may contain a specific exclusion related to a topic addressedin a Coverage Policy. In the event of a conflict, a customer’s benefit ... ribonucleic acid (RNA) of disease-causing microorganisms, including viruses, bacteria and fungi, including yeast, for the purpose of diagnosis and treatment. The scope of this Coverage Policy (CP ...

  Pathogens, Testing, Acid, Bacteria, Exclusion, Fungi, Nucleic, Nucleic acid pathogen testing